I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 12 studies | 38% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 12 studies | 38% ± 11% |
Insufficient scRNA-seq data for expression of MARCHF10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 98% | 123.39 | 87 / 89 | 13% | 0.53 | 121 / 901 |
| lung | 64% | 149.43 | 371 / 578 | 19% | 0.44 | 217 / 1155 |
| brain | 70% | 76.15 | 1858 / 2642 | 12% | 0.25 | 87 / 705 |
| prostate | 53% | 27.35 | 131 / 245 | 4% | 0.07 | 18 / 502 |
| intestine | 46% | 26.41 | 440 / 966 | 1% | 0.02 | 5 / 527 |
| uterus | 35% | 46.79 | 60 / 170 | 7% | 0.17 | 34 / 459 |
| skin | 32% | 78.35 | 587 / 1809 | 3% | 0.06 | 13 / 472 |
| esophagus | 23% | 10.74 | 339 / 1445 | 3% | 0.06 | 6 / 183 |
| ovary | 7% | 2.02 | 12 / 180 | 17% | 0.39 | 75 / 430 |
| stomach | 21% | 9.81 | 74 / 359 | 0% | 0.00 | 1 / 286 |
| breast | 8% | 6.12 | 35 / 459 | 12% | 0.29 | 139 / 1118 |
| pancreas | 3% | 0.88 | 9 / 328 | 7% | 0.27 | 13 / 178 |
| thymus | 4% | 2.84 | 27 / 653 | 5% | 0.07 | 33 / 605 |
| bladder | 0% | 0 | 0 / 21 | 8% | 0.17 | 40 / 504 |
| spleen | 8% | 2.35 | 19 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 7% | 2.92 | 94 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 7% | 2.81 | 79 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 3% | 1.59 | 9 / 258 | 2% | 0.02 | 4 / 230 |
| liver | 1% | 0.62 | 2 / 226 | 2% | 0.05 | 9 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
| peripheral blood | 2% | 1.03 | 18 / 929 | 0% | 0 | 0 / 0 |
| heart | 1% | 0.16 | 5 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 1.29 | 4 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0016740 | Molecular function | transferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MARCHF10 |
| Protein name | RING-type E3 ubiquitin transferase (EC 2.3.2.27) Probable E3 ubiquitin-protein ligase MARCHF10 (EC 2.3.2.27) (Membrane-associated RING finger protein 10) (Membrane-associated RING-CH protein X) (MARCH-X) (RING finger protein 190) (RING-type E3 ubiquitin transferase MARCHF10) Membrane associated ring-CH-type finger 10 |
| Synonyms | MARCH10 RNF190 hCG_2039713 |
| Description | FUNCTION: E3 ubiquitin-protein ligase (Probable). E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. . |
| Accessions | ENST00000456609.6 ENST00000311269.10 ENST00000544856.6 J3KTN9 ENST00000582568.1 ENST00000583803.1 Q8NA82 ENST00000583600.5 ENST00000580520.5 G3V1Q5 J3QLJ2 J3QRH7 J3KTK3 |
